Vyhledávat v databázi titulů je možné dle ISBN, ISSN, EAN, č. ČNB, OCLC či vlastního identifikátoru. Vyhledávat lze i v databázi autorů dle id autority či jména.

Projekt ObalkyKnih.cz sdružuje různé zdroje informací o knížkách do jedné, snadno použitelné webové služby. Naše databáze v tuto chvíli obsahuje 3151204 obálek a 950590 obsahů českých a zahraničních publikací. Naše API využívá většina knihoven v ČR.

Registrovat »    Zapomenuté heslo?

Fundamentals of securities regulation

Autor: Louis Loss, Joel Seligman
Rok: 2003
ISBN: 9780735541993
OKCZID: 110035009

Citace (dle ČSN ISO 690):
LOSS, Louis. Fundamentals of securities regulation. 5th ed. New York: Aspen Publishers, 2004. xxxvi, 1602 s.


Anotace

Fundamentals of Securities Regulation gives you quick access to the law of securities regulation as found in Loss, Seligman, and Paredes’ 11-volume, landmark treatise Securities Regulation —consolidated into one comprehensive volume. Distilling the essence of Loss, Seligman, and Paredes’ 11-Volume master work, this 1,600-page volume reviews and analyzes the most significant aspects of securities regulation and gives you the quick answers you need...when you need them. Fundamentals of Securities Regulation details the rules and regulations affecting the securities market, providing comprehensive coverage and plain-English explanations in a single volume. Through annual supplementation, you’ll keep pace with the ever-increasing volume of litigation, and receive up-to-date examinations of recent regulatory developments and court cases. You will benefit from current coverage of: The SEC’s amendments to the executive compensation and related-party disclosure rules The SEC’s revised shelf offering process The SEC’s amendments to its accelerated filer deadlines for large accelerated filers The SEC’s approval of the application of the Nasdaq to become a national securities exchange Comprehensive amendment of the SEC’s penny stock rules The SEC’s proposed amendments to the tender offer best price Rules 13e-4 and 14d-10 Case developments including Merrill Lynch, Pierce, Fenner & Smith, Inc. v. Dabit, Kircher v. Putnam Funds Trust, and Dura Pharmaceuticals v. Broudo And more!


Dostupné zdroje

Přidat komentář a hodnocení